热门搜索：

巴克莱-全球投资组合经理文摘：争分夺秒（英译中）

金融2023-05-26-未知机构巡***

AI智能总结

The provided document appears to be an extensive report with multiple sections discussing various financial aspects related to companies like Barclays, Haleon, and others. The report includes detailed analysis, data on earnings per share (EPS), stock prices, and percentage changes from previous years. Key points include:

Overview of Companies: The document discusses several companies including Haleon, Amplitude, CVS, and others. It provides insights into their financial health, market performance, and potential future growth based on historical data.
Financial Performance Analysis: There is a comprehensive analysis of the financial performance of these companies, highlighting their earnings, revenue, and stock price movements over time. This includes both pre-pandemic and post-pandemic performance metrics.
Key Financial Indicators: Important indicators such as EPS (Earnings Per Share), SPX (Stock Price Index), and percentage changes in stock prices are analyzed. These help in understanding the overall health and market perception of the companies.
Stock Performance Over Time: Detailed charts and tables illustrate how these companies' stocks have performed over specific periods, including comparisons against broader market indices like SPX.
Investor Contact Information: Contact details for various analysts at Barclays are provided, which might be useful for investors seeking further information or insights.
Market Predictions: The document makes predictions about the companies' future performance, often based on current trends and historical data.
Detailed Analysis of Specific Companies: For companies like Haleon and Amplitude, there is a deep dive into their financial metrics, including EPS, stock prices, and percentage changes. This analysis helps in understanding their position in the market and potential investment opportunities.

Overall, the report serves as a comprehensive guide for investors looking to understand the financial dynamics and potential returns associated with the mentioned companies.

A g 20235$7$ A¼ę  4ƒ˚#$%&'()â+,, /nLAq $./$4236$1$45674892:˚; i(Ba+rcrlasyst)u <fl,>?@,Aƒ#$%67@@DEF½, 4ƒ 4 HIX$J42K“N№N”˚OPQ<$J$J4 Av$xy‰|±@6~ 5 ST;VWX ‰$ #$%,Y‡[+,½]^_`˚ ƒ№Jƒ——42Ⓒ 6 gOPcd,#$%67e`42,f▲500hiñkl˚ A4‰$ Av$xy±˚v$xy½]<— OP:ÆÇÈÉ№Ë‰ 7 $½&:4$: ¡¢¼|±˚ :ÍÅÆ],DÏÐ$$ÑÒ8 £¤¥,§¨©ª«ƒ&¬3.5-4%,▲®¯°ƒ TÓ$ ¼D±,²¿´A˚µ¶®fl,OP¸d¹º i:Õtu 10 V¼,½¾¿¢ƒ,À½ÁÂ(ÄÅ5) ƒ×tu$  ƒ№J?ƒ˚‰t3 ¢№Þ‡[4ĝàkáâ ØÚ 12 ãä˚OP¸d3½/TÓæçÆèƒÀQ½tu ¢$ ì]ĝà,í“îzA”¨©^$ðQ:№˚ôk ĆYć$$,ùúĉ$X 13 ‰t42,“õ÷ø”,ùúOPú—ÈETª,ü&/$$ ýþ£ÿĀ※ĂăînĄîą(ÄÅ6). Ċgª« 14 ® 6$5-15(pagke4) Ď№ⒸQ ;g% ěĜ% īĬ4ĭÇįTÓ 20 95% ½ġƒ¾Ă: 90% 20% CVSxyĲ‰ĴĲĵëķĸⒸļ+I ĲĹĺ 23 85% Prepandemic7y 15% Ľľ 80% LAqĿç 2 75% 10% ‰ƒ¾ĂIõQ 19 70% 5% Tłƒ¾ĂIõQô$gĚŃł 21 65%60% 0%-5% ]QQ˚Ņ4kâ,ňĘŉŊQ½4 ņŇ 12$-98 Dec-01Dec-04 Dec-07 12$10 Dec-13 Dec-16 12$19$12$22$ @œŔĄŐ÷№ŕŖ Đ—đâđ$ē,№÷¸J¿№$ĘęĚěĜ№_ƒĞ3|ęĚğę øČ№A ‰Ď ½ġƒ¾Ă:ĤĥĦħ,i+Ç±ŠĪ, ŌōÁ®№ŏ,Ő÷őŒ Şgş<4/28/2023 %EPSSPXś¾ŝSPXEPS%Surp(RHS) OPg3LAqRŘřŚ˚ ŠšŢ:ÑŤťĲŦŧ½ĲLAqg(½i+‰t½Ū:ÆÇÈÉ№Ë‰1-May-23) Ď@çÅ«Ŭ¼$,Dŭô$Ůů½4 Űłƒgi+7ű±Ųųg<ŵŚ¼$Ŷŷgâ№ŏƒ‰źŻ2242.LAq|<;Ł4 žQ$ƀľŚƁƂƃF˚fl¨Ƅƅ Ç42Ɔ3ĆƇâƈƉ˚ $øŌō´®№FÆÇg№ŏ,ƋƌƍPAGE25. LAqĎ¿№4/ĄŌƎƏ¿№k—EHY¾ÂƆ¿№flg±3Ōgâ$ƓƔ˚°fl,¼$ƒ§ƕŝú§¿№42$— 42ƖƗĎâľƘ½ Çƙƚ˚¼$ƒÇƜĎâş<Ɲ@¼ƃ$ƞ—°Ɵ˚ $øŌō´®‰g№ŏ,ƋƌƍPAGE29. ĘŉŊQ½(S),Ƌƌ½ÄÅ25. LAqĿç ĭµ,Ɖ4ƠơƢƣ $Jĭµ/Ơơùƣ ƋAŒŕŖüƒƤ|ĭµ,Ɖ4ƠơƢƣƥƦTƧ 842ƨ:ƪƫ15:00A/3i+Ƭ% LAqƴ№ƵƶƠơùƣ 5$9$ 3i+Ƭ%lƭ12:45GMT/45A ƴ$▲¼$ĭµ 842 842 5$9$ ƭ10A ƨ:ƪƫ16:00pm/3i+Ƭ% ƭ11 lƭ18:00GMT/3i+Ƭ%lƭ2 KOLĭµ:øƒ№Ƹƹƺƻ½Qg/ƒƽƾ ¿Ő”&ǁǂ1q23ǃÆÇưuâLAq№ǄTÓĭµ 5$9$A Q|¸ǅ:èǆǇ½ 5$9$ $ƯA ƆǏ$Ǒǒ|&½ǔǉ·‡Ǖǖµ 5$9$ ƨ:Ʈƫƒ‰lƭ14:00/i+Ƭ% ǈǉƭĹǊ]ĴǋǌǍ–CogentBiosciences(COGT3 5$10$ 5$10$ 5$11$ ƨ:ƪƫ15:00A/3i+Ƭ% ƭ10A lƭ17:00GMT/Ƭ%lƭ12:00 ‡ǕŬuƒǙǚǛǜ,Ɖ ǝǞǟµKBǠ¾ų №фǣ:ǤŒ3]Ǧǧ 5$12$ 5$12$ ƨ:Ʈƫƒ‰lƭ14:00/i+Ƭ% $ƯA ǫǬ¿№:ESG¼ŬǭĲǮ4ŷ¬°Ɵ ‰Ƴ#AǋǱ 5$11$ lƭ18:00GMT/3i+Ƭ%lƭ2 A ,½#$%&,$ƒfiBonilla 5$15$ lƭ17:00GMT/Ƭ%lƭ—A Ʊ:2024Ğ½kÑ 5$15$ 12:30GMT/7Aư ǝǞǟµƆAmadeusCEO 5$17$ 5$18$ 5$19$ ƨ:Ʈƫƒ‰lƭ14:00/i+Ƭ% $ƯA lƭ13:00GMT/lƭ15:00 Ɔų¾:Vimian(Vimian) +IǳǴǳŠ(IFF3ƆTÓ¼$,Å ŬǵVǶǷǸħÇ]ĭµ:ŬǵVĦħ,¾ƒǻ]ǌǼ®№... 5$25$ ƨ:ƪƫ$9:30/<Ʊ ƨ:ƪƫ16:00pm/lƭ17:00 Ɔ_¾ų—ǿȀǑȁĭµǌǍ:ȂAŷƒ(VRTX3 5$22$ ƨ:Ʈƫƒ‰lƭ13:45-/3i+Ƭ%ƭ8A45Ę Ɔ/_ų¾ǖµ:GNStoreNord(GN3 5$24$Ǿ+Ⓒļ(IMBLN3:Ɔų¾№FÆÇ,Ɖ 5$31$ ,Ɖ4ť©Ř CET($QƬ%ƬƳ) ƨ:Ʈƫƒ‰lƭ14:00/i+Ƭ% $ƯA ƨ:ƪƫ16:00pm/3i+Ƭ% TMTȄȅǛǜ,Ɖ $JĿçƒS ƭ11 14:00/ ƋȇǌŅLAqȈĪžQXŪrƂȉ˚ ƨ:Ʈƫƒ‰lƭi+Ƭ% 10 942i$½ġƯťAȊȋ,Ɖ(ȑ 5$11$ ƨ½:ȌƪƫⒸ,Ɖ152:0002A3/3i+Ƭ% Ȓ¬ 5$17-18 ƭAƒ×@ȍ4 FinTechǱ½Ȓ¬ -5$ lƭ17:00GMT/Ƭ%lƭ12:00 ȏȐű,Ɖ ăAȓ‰ȕȖ‰ȗ 5_Șv/ŠĪ,Ɖ$31$ ƨ:ƪƫ16:00pm/3i+Ƭ%t 6$1$ 6$12-13$ ƭ11șȚƵƶTÓ,Ɖ ƨ:Ʈƫƒ‰lƭ12:00/3i+Ƭ %LAq7AAȇƠ4ƒ×Ħħ,Ɖ Ȓ¬ Ȓ¬ (ȑ 6$14$▲15$ ½ġ,Ɖ Ȓ¬țȜA: 6$21-22$ȝȞĲ½,4ƫƒ×tu¿№2023]Ǚǚ £№№ȟ( $Jĭµ,ƉƠơùƣ/,Ɖ ƋAŒŕŖ÷Ƞ—№Ǵ½ĭµ,Ɖ´ƣ4ƠơƢƣ/ƣľ˚ 5$5$ ƆȡȢȣȤȥ|ȦȧA·ȨȩȪ4ȫ(·№AȬǝǞǟµ 5$5$ Schibstedųȭ,Ɖ £№№ȟ(ïȯ) $Jĭµ,ƉƠơùƣ/,Ɖ 5$5$ LAqĭTȰȱĭTȲřµ 5$5$ 35$4ª 35$4ª ƆHua-JooTan(ȇę¾ȳV3LinerLyticaǙǚǝǞ,Ɖ2025:ȴ(1) 2025:ȴȶ(2) 35$4ª v$xyȷ 35$4ª Ɔų¾:Amplifon(AMP) 35$4ª $½Ⓒ:Đ—đ±ȺȻȼƆƹȽȷȁ 35$4ª HGǫǬ:ƒȾĭȿɀCLOýÇ 35$4ªƆ_¾ų¾Ɂ|ǑȁȀɂǌǍ-IONS 35$4ª Ƀ‰ęşɅɆ,Ɖ®A4ǖȇơ$ɇVɈɉ2ǕÇ 35$4ª 5$3 5$3 5$3 №фǣ:$+:<Ɋ‡Ɍǈ? |:ɍ¾Ɏ $½Ⓒ:ȻȼQ1ɏ Ʊ:Ʊɐɑ|rs$$-g[l—№J? 5$3 5$3 Ǜǜ,Ɖ4ɓɔ@½Ȼ Ǚǚȭ,ƉTeamViewerȣȤȥ|Ȧ4ȣȤ#Ȧ 5$2$ 5$2$ 5$2$ 5$2$ 5$1$ ŬǵVǶǷȻǑÇ]ĭµ 5$1$ LAq№ǄTÓɖ——ɗǖęɘ PennyMac7űī(PFSI3ųǙǚǝǞə] i+Ç±ŠĪĲīĬ4ĭÇį:1Q23¸ǅ4ɚȈɛöǵ;ĝàƂFƒƆLennarCorp.(LEN3ȣȤ#ȦɁ|ǙǚǝǞǟµLAqi+ƴ№ƵƶƠơùƣ /nLAq(BARCLAYS):i+rstu 4ƒ ¢g ¬ɝɞɟɠ +12124127459 joseph.abate@barclays.comBCI,i+ ɡ;i+rstu:4ƒ,5$2$,2023@œ #$%&'()â+,,#$%42,łņ /$36$1$8Ǡ467˚ɢ>¸ë$ƢɤTɇ “Ş№”ɥ˚ªȻ,#$%ɧ89cdŞ ?@ɨĽɩ´NƾɪQ|1.2-1.3fihiñ˚ #$%42“ɬƾ36$ɭkɮ|$.ô$ɯ /$4236$1$˚“#$%ł5ť©HI$JɰȨ42ĆƀcdɱXN№˚ AƒŌ673@D4¸ë½,#$%D,ɲǬ˚OPgcd,Ō67e`4236$5$▲15$Jf▲500hiñkl˚ 6$ɭRɳX$Jć$ɴ+,ɵfiɁ|&Jǟƒ ½89`˚OPQ<$42ɷJɸ&˚ #$%îƒ89¸ëQÈ,űÁÂOPîĞ Kɹɺ˚°fl,OP¸d—B½ú,ƒgQ|ɼƒɨĽĞ˚Ūƒ(½úƒ_:1.2--1.3iñk)˚ ú¾,gƒɼƒ½ú$ʀ19%,_ƒ15.5%2022¾˚ OPQ<Ć42,ƒgÆÇ¢À_@OIS5ʁAĄîfi˚ɢþɼĆgɳɏKOP¸d,$.rsʁ7QĞÁÂƒĂăÕ,°< ōPęþQg˚ rsʁ7ʄ‡¼ęƕʆƒʇƃƒŌiȇɐ$$ J[˚ ®ɏĞɼQ|gÀ_ɥØ№ƒ ¢,7ƒ½]]flƈƉŠĪʋiȇɐ ¢?ǧk˚ LAq:Av$xy ‰|±@6~ ‰g v‰ÁⒸ $½gʕ•ʖ‰ǉ +44(0)2077733616 iain.simpson@barclays.com ø+LAq| ȫ(·№AȬ +44(0)2031341903 warren.ackerman@barclays.com ø+LAq| ƒⒸʷ© ;ʺƒ,CFA +44(0)2077736263 emily.field@barclays.com ø+LAq| i+˓˔Ɔ˕Š $½ǈ(·r· gȬ +12125263112 lauren.lieberman@barclays.comBCI,i+ i+ƵƶłⒸ4ɺɑʷ© ȧťMiksic +12125269189 matt.miksic@barclays.comBCI,i+ ɡ;Av$xy:‰|±@6,~,20235$3$@œ v$xy½]<—4¼|±˚OPúXʍfiĜ½ɴFƬ$Ć$½&ʏ°Ɵ4$: ¡¢˚Ɂ]tuēÒŷX;$Ⓒļ,ʐƒKŇęʒ3Ŭ,˚OP ïȯʓHaleon4îƢɤĸ˚ —ƒ×4¼|±:3ʍ&—¼ʚv$xyĞʛ(ŐĽKŷƒ3¿№ʚ%%ř,YDʜƅ ¼$ùŖŖʝ§¨©[ʟ˚°fl,OPQ<§¨©$Ń¿№ʠƒX(v$xy/fi %ĘDKōP▲®øʢA34¼$(v$xy%ř‰‰DǖîƢɤ¿№¼ɪʤ▲ø´®3˚3í,63ǿšK ʦĂ˚HaleonȠ£WƟ¥Aƒ]@š,KenvueIPO@ʪRǿšʫ3ʬʭ,ʮʯ 633QțŮův$xy#â,ŘVʰʱʲʳʴÇƜŌ½ġ(ʳʴʵʶX3˚ ½&,ɢⒸ¨ų42,$ôʦʼ:£OPƆ¼$ǖµʽʾv$xy¨©øČQǱKŌ ½&¢˚“Ć¨©K&3%ʿK&5%?”K/ OP£¼$g$ăúĽ½ˁ˚£¤¥,§¨©˂ƒ&c.3.5-4%,ɢOPƒŌ▲®¯°ƒ¼D±4²¿ǖ ▲®ƌƆ$˚k§¨©<´A¿№˃˄3ɺƾ &¢Ŗ½5%˚/ʄ,OP¸dV¼¹º,½V¼ƒ ¾¿,kÀǖ§¨©½ÁÂ˚íˆ,gOP225$31$ˇ,,xyv,OPƒxy4ǫxƒ<ˈȯv$Ğ˂ˉ, ƒÀ$šN+vˋˌ˚OPQ<▲®Ǯ ¿№®ʓv$¨©—ˍˎȋ§¨©,íDKƵƶǫx¨©;OPúĆş<—|±3ʦʼɢˏ$—¼Ñ®Nˑ˒˚ Ɂ]tuēÒŷX;$ⒸļY@ˈ_ ¡Ĳʐƒ4ŇęŬ,:3Ğ˗4ĞfiŞƒ×tu,ɨǃ[ƒN˄ņAŐ÷ƒ˘ȈĪ˚3Ćƀ+]$ĞfiŞ+]˙$ŲųʽʾƒǠô$ýË‰,˚‡X½˜˘@6˚—¾№ ¼$øʢK;$Ⓒļ3˟№,ɢĆQƒ$ƀ ?;˚—‰šˢ,M$øˤ+]˥ȊOTCHÍȈĪƒǠɃ‰kȻƒⒸ,Y˦$A+½ƒǠ½˜˘˚°fl, ƒi+/ø+/ëĞ ˨/½˩ĞȻƄƅȻ

点击免费查看完整报告